Trial Outcomes & Findings for The Use of Bispectral Index Monitoring to Assess Depth of Sedation in Patients With Traumatic Brain Injury (NCT NCT03575169)

NCT ID: NCT03575169

Last Updated: 2026-08-10

Results Overview

Mean BIS of patients sedated. BIS is a processed EEG value ranging from 0 to 100, with lower values representing decreased brain activity. The usual range for General Anaesthesia is 40-60.

Recruitment status

COMPLETED

Target enrollment

26 participants

Primary outcome timeframe

24 hours

Results posted on

2026-08-10

Participant Flow

Participant milestones

Participant milestones
Measure
Patients With TBI
Admitted to Aberdeen ICU with diagnosis of TBI and expected to require greater than 24 hours sedation. BIS Monitor: Unilateral BIS electrode
Overall Study
STARTED
26
Overall Study
COMPLETED
26
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Patients With TBI
n=26 Participants
Admitted to ICU with diagnosis of TBI and expected to require greater than 24 hours sedation. BIS Monitor: Unilateral BIS electrode
Age, Continuous
41 years
n=26 Participants
Sex: Female, Male
Female
4 Participants
n=26 Participants
Sex: Female, Male
Male
22 Participants
n=26 Participants

PRIMARY outcome

Timeframe: 24 hours

Mean BIS of patients sedated. BIS is a processed EEG value ranging from 0 to 100, with lower values representing decreased brain activity. The usual range for General Anaesthesia is 40-60.

Outcome measures

Outcome measures
Measure
Patients With TBI
n=26 Participants
Admitted to Aberdeen ICU with diagnosis of TBI and expected to require greater than 24 hours sedation. BIS Monitor: Unilateral BIS electrode
Mean BIS for Population Over 24 Hours
38 BIS value (index)
Interval 29.0 to 44.0

SECONDARY outcome

Timeframe: 24 hours

Mean ICP of sedated patients

Outcome measures

Outcome measures
Measure
Patients With TBI
n=26 Participants
Admitted to Aberdeen ICU with diagnosis of TBI and expected to require greater than 24 hours sedation. BIS Monitor: Unilateral BIS electrode
Mean ICP for Population Over 24 Hours
11 mmHg
Standard Deviation 6

SECONDARY outcome

Timeframe: 24 hours

Number of instances of osmotherapy use in sedated patients

Outcome measures

Outcome measures
Measure
Patients With TBI
n=26 Participants
Admitted to Aberdeen ICU with diagnosis of TBI and expected to require greater than 24 hours sedation. BIS Monitor: Unilateral BIS electrode
Incidence of Osmotherapy Use for Population Over 24 Hours
35 Events

SECONDARY outcome

Timeframe: 24 hours

Total vasopressor dose for sedated patients

Outcome measures

Outcome measures
Measure
Patients With TBI
n=26 Participants
Admitted to Aberdeen ICU with diagnosis of TBI and expected to require greater than 24 hours sedation. BIS Monitor: Unilateral BIS electrode
Median Vasopressor Dose for Population Over 24 Hours
0.11 mcg/kg/min
Interval 0.04 to 0.23

SECONDARY outcome

Timeframe: 24 hours

Total sedative dose for sedated patients

Outcome measures

Outcome measures
Measure
Patients With TBI
n=25 Participants
Admitted to Aberdeen ICU with diagnosis of TBI and expected to require greater than 24 hours sedation. BIS Monitor: Unilateral BIS electrode
Sedative Dose for Population Over 24 Hours
1.95 mg/kg/hr
Interval 1.42 to 2.14

SECONDARY outcome

Timeframe: Days to weeks

Number of days admitted to ICU

Outcome measures

Outcome measures
Measure
Patients With TBI
n=26 Participants
Admitted to Aberdeen ICU with diagnosis of TBI and expected to require greater than 24 hours sedation. BIS Monitor: Unilateral BIS electrode
Length of ICU Stay for Population Over 24 Hours
18.2 days
Interval 7.25 to 21.25

Adverse Events

Patients With TBI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 4 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Callum Kaye

NHS Grampian/University of Aberdeen

Phone: 01224559839

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place